InnoTherapy Valuation
| 246960 Stock | KRW 8,480 40.00 0.47% |
At this time, the firm appears to be overvalued. InnoTherapy retains a regular Real Value of W7402.45 per share. The prevalent price of the firm is W8480.0. Our model calculates the value of InnoTherapy from evaluating the firm fundamentals such as Return On Equity of -66.34, shares outstanding of 5.04 M, and Return On Asset of -0.13 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that InnoTherapy's price fluctuation is very steady at this time. Calculation of the real value of InnoTherapy is based on 3 months time horizon. Increasing InnoTherapy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since InnoTherapy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InnoTherapy Stock. However, InnoTherapy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8480.0 | Real 7402.45 | Hype 8440.0 | Naive 8788.09 |
The real value of InnoTherapy Stock, also known as its intrinsic value, is the underlying worth of InnoTherapy Company, which is reflected in its stock price. It is based on InnoTherapy's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of InnoTherapy's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of InnoTherapy helps investors to forecast how InnoTherapy stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InnoTherapy more accurately as focusing exclusively on InnoTherapy's fundamentals will not take into account other important factors: InnoTherapy Total Value Analysis
InnoTherapy is presently forecasted to have takeover price of 84.92 B with market capitalization of 44.19 B, debt of 17.17 B, and cash on hands of 1.03 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the InnoTherapy fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
84.92 B | 44.19 B | 17.17 B | 1.03 B |
InnoTherapy Investor Information
About 28.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the key measurements obtained from InnoTherapy's financial statements, InnoTherapy is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.InnoTherapy Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. InnoTherapy has an asset utilization ratio of 1.59 percent. This suggests that the Company is making W0.0159 for each dollar of assets. An increasing asset utilization means that InnoTherapy is more efficient with each dollar of assets it utilizes for everyday operations.InnoTherapy Ownership Allocation
The market capitalization of InnoTherapy is W44.19 Billion. InnoTherapy secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.InnoTherapy Profitability Analysis
The company reported the revenue of 507.29 M. Net Loss for the year was (5.04 B) with profit before overhead, payroll, taxes, and interest of 339.33 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates InnoTherapy's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in InnoTherapy and how it compares across the competition.
About InnoTherapy Valuation
The stock valuation mechanism determines InnoTherapy's current worth on a weekly basis. Our valuation model uses a comparative analysis of InnoTherapy. We calculate exposure to InnoTherapy's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InnoTherapy's related companies.InnoTherapy, Inc., engages in the development and sale of medical sealant products in South Korea. The company was founded in 2010 and is headquartered in Seoul, South Korea. InnoTherapy is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct InnoTherapy's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates InnoTherapy's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct InnoTherapy's valuation analysis, follow these 8 steps:- Gather financial information: Obtain InnoTherapy's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine InnoTherapy's revenue streams: Identify InnoTherapy's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research InnoTherapy's industry and market trends, including the size of the market, growth rate, and competition.
- Establish InnoTherapy's growth potential: Evaluate InnoTherapy's management, business model, and growth potential.
- Determine InnoTherapy's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate InnoTherapy's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for InnoTherapy Stock analysis
When running InnoTherapy's price analysis, check to measure InnoTherapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnoTherapy is operating at the current time. Most of InnoTherapy's value examination focuses on studying past and present price action to predict the probability of InnoTherapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnoTherapy's price. Additionally, you may evaluate how the addition of InnoTherapy to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |